LMAT

$82.001.31%1.06

Lemaitre Vascular Inc (LMAT)

Date: O: H: L: C: Vol:

Precedente Chiudi:

$80.94

Aprire:

$81.80

Volume 24 ore:

30,327

Volume relativo:

0.11

Capitalizzazione di mercato:

$1.88B

Reddito:

$256.28M

Utile/perdita netta:

$62.40M

Rapporto P/E:

30.21

EPS:

$2.71

Flusso di cassa netto:

$79.12M

1W Prestazione:

-2.74%

1M Prestazione:

+3.85%

6M Prestazione:

-26.81%

1Y Prestazione:

-5.32%

Intervallo 1D:

$81.48$82.39

Intervallo di 1 settimana:

$80.03$85.65

Portata 52W:

$78.22$118.01

Profilo aziendale di Lemaitre Vascular Inc (LMAT)

Nome

Lemaitre Vascular Inc

Settore

Healthcare

Industria

Medical Instruments & Supplies

Telefono

781-221-2266

Indirizzo

63 SECOND AVENUE, BURLINGTON, MA, USA

Dipendente

655

@LMAT_Vascular

Prossima data di guadagno

2026-11-04

Ultimi documenti SEC

SEC

Discussioni di LMAT su X

Confronta LMAT con ISRG, BDX, ALC, RMD, WST

Azioni	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
LMAT Lemaitre Vascular Inc	$1.88B	$262.43M	$65.67M	$79.12M	$2.71
ISRG Intuitive Surgical Inc	$155.19B	$11.58B	$2.96B	$3.22B	$8.73
BDX Becton Dickinson Co	$53.92B	$20.84B	$941.00M	$3.07B	$3.94
ALC Alcon Inc	$35.46B	$224.23M	-$39.99M	$1.59B	$1.66
RMD Resmed Inc	$32.12B	$5.73B	$1.59B	$1.74B	$10.37
WST West Pharmaceutical Services Inc	$28.84B	$3.40B	$638.90M	$458.00M	$7.48

Lemaitre Vascular Inc Azioni (LMAT) Upgrade e downgrade

Data	Azione	Analista	Modifica della valutazione
2026-08-05	Downgrade	Barrington Research	Outperform → Mkt Perform
2025-08-06	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2025-02-28	Downgrade	Barrington Research	Outperform → Mkt Perform
2025-02-28	Downgrade	Oppenheimer	Outperform → Perform
2025-02-13	Iniziato	Wells Fargo	Equal Weight
2024-10-15	Iniziato	Cantor Fitzgerald	Neutral
2024-08-02	Resumed	Lake Street	Buy
2024-05-31	Resumed	ROTH MKM	Buy
2024-04-26	Aggiornamento	Stifel	Hold → Buy
2024-02-06	Resumed	KeyBanc Capital Markets	Sector Weight
2023-10-23	Iniziato	JMP Securities	Mkt Outperform
2023-09-06	Iniziato	Oppenheimer	Outperform
2023-08-03	Downgrade	Jefferies	Buy → Hold
2023-05-03	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2022-10-28	Downgrade	Barrington Research	Outperform → Mkt Perform
2021-09-16	Iniziato	Jefferies	Buy
2021-02-12	Iniziato	KeyBanc Capital Markets	Sector Weight
2020-03-16	Aggiornamento	Sidoti	Neutral → Buy
2019-10-24	Downgrade	First Analysis Sec	Strong Buy → Outperform
2019-10-24	Aggiornamento	Lake Street	Hold → Buy
2019-10-14	Aggiornamento	First Analysis Sec	Outperform → Strong Buy
2019-07-25	Reiterato	Barrington Research	Outperform
2019-07-25	Aggiornamento	First Analysis Sec	Neutral → Outperform
2018-10-08	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2018-10-08	Aggiornamento	ROTH Capital	Neutral → Buy
2018-06-08	Resumed	ROTH Capital	Buy
2018-04-26	Downgrade	Stifel	Buy → Hold
2018-04-26	Aggiornamento	The Benchmark Company	Hold → Buy
2017-10-27	Downgrade	First Analysis Sec	Overweight → Equal-Weight
2017-10-27	Downgrade	The Benchmark Company	Buy → Hold
2017-07-10	Downgrade	Canaccord Genuity	Buy → Hold
2017-07-10	Downgrade	The Benchmark Company	Buy → Hold
2017-03-21	Iniziato	First Analysis Sec	Overweight
2017-02-22	Downgrade	Barrington Research	Outperform → Mkt Perform
2016-09-22	Downgrade	Sidoti	Buy → Neutral
2016-07-28	Reiterato	Barrington Research	Outperform
2016-02-25	Reiterato	Barrington Research	Outperform

Lemaitre Vascular Inc Azioni (LMAT) Dati Finanziari

Periodo	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Data di fine periodo	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue USD (M)	249.60	219.86	193.48	161.65	154.42
Cost of revenue USD (M)	71.06	68.96	66.44	56.76	53.04
Gross profit USD (M)	178.54	150.90	127.05	104.90	101.38
Research and development USD (M)	14.14	15.65	16.97	13.29	11.80
Operating expenses USD (M)	110.63	98.65	90.34	78.07	64.96
Operating income USD (M)	67.91	52.26	36.71	26.83	36.43
Income before tax USD (M)	75.18	56.88	39.48	27.49	34.29
Income tax expense USD (M)	17.45	12.84	9.37	6.85	7.38
Net income USD (M)	57.73	44.04	30.11	20.64	26.91
Basic EPS USD/shares	2.55	1.96	1.36	0.94	1.27
Diluted EPS USD/shares	2.52	1.93	1.34	0.93	1.25
Basic weighted shares shares (M)	22.64	22.45	22.22	21.98	21.16
Diluted weighted shares shares (M)	22.93	22.78	22.42	22.17	21.48

Lemaitre Vascular Inc Azioni (LMAT) insider trading

BRIDGET A ROSSJul 29 '26
Director
Transazione
Proposed Sale
Costo
$103.94
#Azioni
4,322
Valore ($)
449,241
#Azioni Totale
0
TRENT G KAMKEMay 08 '26
Officer
Transazione
Proposed Sale
Costo
$107.00
#Azioni
2,928
Valore ($)
313,287
#Azioni Totale
0
Kamke Trent GMay 08 '26
Senior V. P., Operations
Transazione
Sale
Costo
$107.00
#Azioni
2,928
Valore ($)
313,287
#Azioni Totale
3,749
LeMaitre George WMay 08 '26
Chairman and CEO
Transazione
Sale
Costo
$108.69
#Azioni
27,881
Valore ($)
3,030,400
#Azioni Totale
1,430,019
Jasinski Lawrence JMay 07 '26
Director
Transazione
Option Exercise
Costo
$65.92
#Azioni
2,858
Valore ($)
188,412
#Azioni Totale
8,657
Jasinski Lawrence JMay 07 '26
Director
Transazione
Sale
Costo
$110.00
#Azioni
3,943
Valore ($)
433,730
#Azioni Totale
4,714
BRIDGET A ROSSMay 07 '26
Director
Transazione
Proposed Sale
Costo
$111.10
#Azioni
5,044
Valore ($)
560,366
#Azioni Totale
0
LAWRENCE J. JASINSKIMay 07 '26
Director
Transazione
Proposed Sale
Costo
$110.00
#Azioni
3,943
Valore ($)
433,730
#Azioni Totale
0
LeMaitre George WMay 07 '26
Chairman and CEO
Transazione
Sale
Costo
$107.64
#Azioni
18,600
Valore ($)
2,002,013
#Azioni Totale
1,457,900
Ross Bridget AMay 07 '26
Director
Transazione
Option Exercise
Costo
$48.15
#Azioni
5,044
Valore ($)
242,882
#Azioni Totale
8,986

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
BRIDGET A ROSS	Director	Jul 29 '26	Proposed Sale	$103.94	4,322	449,241	0
TRENT G KAMKE	Officer	May 08 '26	Proposed Sale	$107.00	2,928	313,287	0
Kamke Trent G	Senior V. P., Operations	May 08 '26	Sale	$107.00	2,928	313,287	3,749
LeMaitre George W	Chairman and CEO	May 08 '26	Sale	$108.69	27,881	3,030,400	1,430,019
Jasinski Lawrence J	Director	May 07 '26	Option Exercise	$65.92	2,858	188,412	8,657
Jasinski Lawrence J	Director	May 07 '26	Sale	$110.00	3,943	433,730	4,714
BRIDGET A ROSS	Director	May 07 '26	Proposed Sale	$111.10	5,044	560,366	0
LAWRENCE J. JASINSKI	Director	May 07 '26	Proposed Sale	$110.00	3,943	433,730	0
LeMaitre George W	Chairman and CEO	May 07 '26	Sale	$107.64	18,600	2,002,013	1,457,900
Ross Bridget A	Director	May 07 '26	Option Exercise	$48.15	5,044	242,882	8,986

Lemaitre Vascular Inc Borsa (LMAT) Ultime notizie

Oct 31, 2026